Imatinib radiosensitizes bladder cancer by targeting homologous recombination.
Radiotherapy is a major treatment modality used to treat muscle-invasive bladder cancer, with patient outcomes similar to surgery. However, radioresistance is a significant factor in treatment failure. Cell-free extracts of muscle-invasive bladder tumors are defective in nonhomologous end-joining (N...
Main Authors: | Qiao, B, Kerr, M, Groselj, B, Teo, M, Knowles, M, Bristow, R, Phillips, R, Kiltie, A |
---|---|
Format: | Journal article |
Sprog: | English |
Udgivet: |
2013
|
Lignende værker
-
Targeting homologous recombination using imatinib results in enhanced tumor cell chemosensitivity and radiosensitivity.
af: Choudhury, A, et al.
Udgivet: (2009) -
E3 ligase cIAP2 mediates downregulation of MRE11 and radiosensitization in response to HDAC inhibition in bladder cancer
af: Nicholson, J, et al.
Udgivet: (2017) -
Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression
af: Groselj, B, et al.
Udgivet: (2013) -
Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression.
af: Groselj, B, et al.
Udgivet: (2013) -
The HDAC Inhibitor Panobinostat Promotes Expression of Delta 133p53 Variants in TP53 Wild-type Bladder Cancer Cells
af: Groselj, B, et al.
Udgivet: (2012)